Hyophen Tablets and Mogamulizumab-kpkc Intravenous
Determining the interaction of Hyophen Tablets and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate
Brand name: Hyophen, Prosed/DS, Urophen MB
Synonyms: Hyophen
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyophen Tablets-Molindone
- Hyophen Tablets-Mometasone (Oral Inhalation)
- Hyophen Tablets-Mometasone and Formoterol
- Hyophen Tablets-Mometasone and formoterol Inhalation
- Hyophen Tablets-Mometasone Cream
- Hyophen Tablets-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Hyoscine Injection
- Mogamulizumab-kpkc Intravenous-Hyoscyamine
- Mogamulizumab-kpkc Intravenous-Hyoscyamine and phenyltoloxamine
- Mogamulizumab-kpkc Intravenous-Hyoscyamine Extended-Release Tablets
- Mogamulizumab-kpkc Intravenous-Hyoscyamine Injection
- Mogamulizumab-kpkc Intravenous-Hyoscyamine Liquid